Journal Browser

► Journal Browser

Special Issue Editors

Prof. Dr. Jack Van Horssen

E-Mail Website
Guest Editor

Department of Molecular Cell Biology and Immunology, VU University Medical Center Amsterdam, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
Interests: immunohistochemistry; neuropathology; neuroinflammation; mitochondrial dysfunction; Nrf2; antioxidant enzymes; multiple sclerosis

Dr. Maarten E. Witte

E-Mail
Co-Guest Editor

Department of Molecular Cell Biology and Immunology, VU University Medical Center Amsterdam, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
Interests: neuroinflammation; neurodegeneration; mitochondrial biology; energy metabolism; oxidative stress

Special Issue Information

Dear Colleagues,

Reactive oxygen species (ROS) are continuously produced in the central nervous system (CNS) by ROS-generating enzymes, such as NADPH oxidases, and by mitochondria. Importantly, ROS are efficiently detoxified by endogenous cytosolic and mitochondrial antioxidant enzymes in order to prevent oxidative injury to vulnerable CNS cells. However, in neuroinflammatory diseases, ROS production exceeds the antioxidant capacity. This results in irreversible oxidative damage to essential cellular structures, and eventually leads to neuronal loss. The aim of this special issue is to provide a comprehensive overview on the involvement of oxidative stress in neuroinflammatory conditions. Specific topics include:

1. Elucidation of the (sub)cellular origin of ROS during a neuroinflammatory attack and the molecular processes that are involved in this process.

2. Therapeutic potential of endogenous antioxidants in neuroinflammation, including transcriptional regulation of antioxidant enzymes, such as the Nrf2 and PGC-1α pathway.

Prof. Dr. Jack van Horssen
Dr. Maarten E. Witte
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

neurodegenerative diseases (Parkinson, Alzheimer)
ROS-generating enzymes (NADPH oxidase, NOS)
neuroinflammation
Nrf2 and PCG-alpha pathway
exogenous antioxidants
mitochondrial antioxidants
microglia activation
meningeal inflammation
antioxidant therapy
oxidative stress

Published Papers (2 papers)

Download All Papers

Research

Jump to: Review

1163 KiB

Open AccessArticle

Oxidative Stress Is Associated with Neuroinflammation in Animal Models of HIV-1 Tat Neurotoxicity

by Jean-Pierre Louboutin, Lokesh Agrawal, Beverly A. S. Reyes, Elisabeth J. Van Bockstaele and David S. Strayer

Antioxidants 2014, 3(2), 414-438; https://doi.org/10.3390/antiox3020414 - 16 May 2014

Cited by 13 | Viewed by 8421

Abstract

HIV-1 trans-acting protein Tat, an essential protein for viral replication, is a key mediator of neurotoxicity. If Tat oxidant injury and neurotoxicity have been described, consequent neuroinflammation is less understood. Rat caudate-putamens (CPs) were challenged with Tat, with or without prior rSV40-delivered superoxide dismutase or glutathione peroxidase. Tat injection caused oxidative stress. Administration of Tat in the CP induced an increase in numbers of Iba-1- and CD68-positive cells, as well as an infiltration of astrocytes. We also tested the effect of more protracted Tat exposure on neuroinflammation using an experimental model of chronic Tat exposure. SV(Tat): a recombinant SV40-derived gene transfer vector was inoculated into the rat CP, leading to chronic expression of Tat, oxidative stress, and ongoing apoptosis, mainly located in neurons. Intra-CP SV(Tat) injection induced an increase in microglia and astrocytes, suggesting that protracted Tat production increased neuroinflammation. SV(SOD1) or SV(GPx1) significantly reduced neuroinflammation following Tat administration into the CP. Thus, Tat-induced oxidative stress, CNS injury, neuron loss and inflammation may be mitigated by antioxidant gene delivery. Full article

(This article belongs to the Special Issue Free Radicals and Antioxidants in Neuroinflammation)

► Show Figures

Figure 1

Review

Jump to: Research

823 KiB

Open AccessReview

Oxidative Stress and the Use of Antioxidants in Stroke

by Rachel Shirley, Emily N. J. Ord and Lorraine M. Work

Antioxidants 2014, 3(3), 472-501; https://doi.org/10.3390/antiox3030472 - 03 Jul 2014

Cited by 195 | Viewed by 12792

Abstract

Transient or permanent interruption of cerebral blood flow by occlusion of a cerebral artery gives rise to an ischaemic stroke leading to irreversible damage or dysfunction to the cells within the affected tissue along with permanent or reversible neurological deficit. Extensive research has identified excitotoxicity, oxidative stress, inflammation and cell death as key contributory pathways underlying lesion progression. The cornerstone of treatment for acute ischaemic stroke remains reperfusion therapy with recombinant tissue plasminogen activator (rt-PA). The downstream sequelae of events resulting from spontaneous or pharmacological reperfusion lead to an imbalance in the production of harmful reactive oxygen species (ROS) over endogenous anti-oxidant protection strategies. As such, anti-oxidant therapy has long been investigated as a means to reduce the extent of injury resulting from ischaemic stroke with varying degrees of success. Here we discuss the production and source of these ROS and the various strategies employed to modulate levels. These strategies broadly attempt to inhibit ROS production or increase scavenging or degradation of ROS. While early clinical studies have failed to translate success from bench to bedside, the combination of anti-oxidants with existing thrombolytics or novel neuroprotectants may represent an avenue worthy of clinical investigation. Clearly, there is a pressing need to identify new therapeutic alternatives for the vast majority of patients who are not eligible to receive rt-PA for this debilitating and devastating disease. Full article

(This article belongs to the Special Issue Free Radicals and Antioxidants in Neuroinflammation)

► Show Figures